Thu, Aug 21, 2014, 4:51 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

pagesus52 27 posts  |  Last Activity: Aug 14, 2014 11:45 AM Member since: Jun 15, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Can you say "biased"?

    by fran_frank_lexky May 23, 2014 2:02 PM
    pagesus52 pagesus52 May 23, 2014 10:21 PM Flag

    that was a legendary footer printed on the paper they wrote on, which didn't mean anything. If Lats had been not binding, there would have to be such wording in the signed agreement. That's the reason why it was ignored by the judge. If pip had used the footer as an argument to back out of Lats when the drug had failed, pip would have lost in their case too for the same reason. Besides, the subsequent negotiation on merger and licence further supported the binding force of LATS. I think Supreme made that very clear.

  • pagesus52 pagesus52 May 23, 2014 10:32 PM Flag

    positive step, considering not much cash on hand. It says to siga loud and clear that it is prepared to fight all the way for their rights to st-246 and it has to money to do it.

  • pagesus52 by pagesus52 Jun 4, 2014 2:03 AM Flag

    How P will rule no one knows, of course, but it will most likely be favorable to pip. What if the licence is goven to pip? What impact would it be on pip share price? siga would be in 1.50 range, and pip would jump to 2.50? 40 million would be payable to siga for their efforts, plus persentage of royalty, according to licencing terms if siga had negociated in good faith. To me, that would be the only way pip was compensated for their loss of opportunities, because the Supreme wanted P to look into the signed agreements for relief.

  • Reply to

    ruling comes soon?

    by pagesus52 Jun 4, 2014 2:03 AM
    pagesus52 pagesus52 Jun 4, 2014 12:35 PM Flag

    It's not a scheduled trial or hearing or oral argument. The judge can rule from the bench any time when he is ready. It's already overdue, so any day now.

  • pagesus52 by pagesus52 Jun 12, 2014 10:48 PM Flag

    Does anyone here have a handle of how to evaluate this merger with regard to zlcs? 17% means what exactly?

  • pagesus52 by pagesus52 Jun 14, 2014 9:16 AM Flag

    "Based on these findings and related discussions with Takeda, Affymax has elected not to exercise its rights with respect to the Omontys New Drug Application (NDA). "

  • pagesus52 by pagesus52 Jun 25, 2014 3:22 PM Flag

    who in the right mind wants to sell after waiting almost half a year, except those manipulators, of course. The way it trades tells me we are getting close, before July 4th, that is. Buy if you can. Just my 2 cents.

  • pagesus52 pagesus52 Jul 15, 2014 8:26 AM Flag

    The news has not been released yet, but what it means is that the current shareholder will have the right to purchase additional shares on a 1 for 1 basisi at a certain price, ie., one share gives you the right to purchase one additional share. That is why 5.95m for 5.95m. I would expect a 20% discount. This is a very smart way to raise money. We dilute ourselves. Strong buy.

  • There is no new 6k today. As per 6k July 14, ir requested 81m more shares, but they have not been issued yet. If they are to be issued, they would be 1.6m post split. I doubt ir will sell right after they get it lke they did before. They got most of their money back pre split. Now they want to go long to make more money. In the r/s new release, the company got the written consent of a major shareholder. If it is ir, I don't think they will sell. When there is no major seller, the price has only one way to go -- up. This time, you would wish you not on the short side. The total o/s would be 8.2m. The only issue remaining is the delisting. It would be delisted if sec found concret evidence of wrong doing. I would think they did everything by the book. By the looks of it, it was a well thought out plan to salvage the company in a cliff hanging situation.

  • pagesus52 by pagesus52 Jul 17, 2014 1:38 AM Flag

    sorry, wrong board.

  • pagesus52 by pagesus52 Jul 17, 2014 2:08 AM Flag

    ir requested 81m. If they are issued, it will be 1.6m post split. So, ir could have 1.6m to dump when they get it, but I doubt they will. This time, they would want to hold on the way up to make more money. The selling was way over done. It could be a way to force a r/s. If the major is not selling, the stock will go up, as we saw today. The only issue is the delisting. If sec found evidence of wrong doing, it will be delisted. sec already fired a warning shot. If sec cannot find anything, there would be no reason to delist. From the looks of it, it did everything by the book. It was a well thought out plan to salvage a company in a cliff hanging situation. gltya.

  • at 5.50 is only 11 cents pre split. I think fair value given the delisting risk should be at 7 dollors, 14 cents pre split.

  • pagesus52 by pagesus52 Jul 18, 2014 10:33 AM Flag

    If ther had been no r/s, and stock went from 4 cents to 11 cents, would nasdaq halt the stock? Probably not. People ask why nasdaq never halts the stock on the way down? That's because when a stock goes down, no one will buy, so there is no need to halt. nasdaq is only worried about the new investors. If you are already in it, risk and reward are yours to take.

    Anyways, hope newl will get their acts together and show there has been no wrong doing. If not, I have to say goodbye to my gambled money. Yes, this is a pure gamble. I thought I could get my loss back, but got caught again.

  • pagesus52 by pagesus52 Jul 19, 2014 9:43 AM Flag

    Yes, they filed the application for otc board. It was an initial registration, as many here pointed out. There will be more forms to file if the company has to go there. At this point, it is probably a plan. If it does go there, what's the big deal? You can still trade.

    What I want to know is why they have to go there if they do go there. The idea of r/s is to meet the nasdaq's minimum 1 dollar bidding requirement, so they did that. The closing price stands at 4.41. Does anyone know any other reason why they have to be downgraded to the junior board? Many bashers cry foul. Let's be clear about that. If there has been wrong doing in the past few weeks regarding their balance sheet program (granted a very nice way to put it about a very bad situation), the stock would be halted for good. Suits would be filed. Someone would go to jail. In other words, if they are planning to go to otc, that means they are still a legit comapny. Otherwise, even otc is a too good place for them.

    So, short or long, everyone just chill out and wait for an official announcement from the company.

  • pagesus52 by pagesus52 Jul 22, 2014 11:35 PM Flag

    ignore today's trading, unofficial, a test run, mostly phantom trades, shorts working very hard, tomorrow more of the same, more testing...... people trading between their own accounts, wait for official announcement!!! Just my opinion. Always dd before you buy or sell.

  • pagesus52 by pagesus52 Jul 29, 2014 12:44 AM Flag

    Now that the majors got enough shares through their relentless work, price will climb back to the low 20s starting from tomorrow. Apparently, everything is going well at the trial, and nothing has changed except prospect getting better and more certain. When the positive results are announced, it will fly to 40s. just the way I see it. gl.

  • pagesus52 by pagesus52 Jul 31, 2014 7:56 PM Flag

    'Fast-track the Ebola drug': U.S. under pressure to give potentially life-saving medication the green light as experts warn of global pandemic

    A petition has been launched urging the U.S. Food and Drug Administration to fast-track a new Ebola drug
    There is currently no cure or vaccine for the deadly disease
    But a clinical trial for potentially the first drug was put on hold this month

    672 people have died as the disease sweeps through Western Africa
    Head of global charity calls for experimental drugs to be offered to victims
    Expert says virus is 'as infectious as flu' and poses global pandemic threat
    But specialist said if the disease reaches UK shores the NHS is prepared

    By Lizzie Parry

    Published: 14:58 GMT, 30 July 2014 | Updated: 11:40 GMT, 31 July 2014




    Health campaigners are today calling for U.S. authorities to speed up their approval of a new drug hoped to be the first cure for the deadly Ebola virus.

    There is currently no cure or vaccine for the disease, which has claimed the lives of 672 people in West Africa, since February.

    The head of global charity The Wellcome Trust earlier this month called for experimental drugs to be offered to those diagnosed with the virulent illness in West Africa.

    Despite the drugs not being fully tested Jeremy Farrar, professor of tropical medicine and director of the trust, said Ebola's spread in Guinea, Liberia and Sierra Leone is 'out of control'.

    Scroll down for videos

    Experts say a vaccine to prevent the deadly Ebola virus is between two to six years away from being available to use

    Nigerian health officials are in the process of trying to trace 30,000 people, believed to be at risk of contracting the highly-infectious virus, following the death of Patrick Sawyer in Lagos

    The latest outbreak of Ebola is the most severe since the disease was discovered in 1976. So far the disease has spread from a village in Guinea to Sierr

  • Reply to

    You guys notice!!

    by bigideaportugal Aug 1, 2014 3:50 PM
    pagesus52 pagesus52 Aug 2, 2014 12:02 PM Flag

    That's because some nervous shorts are scared to keep their holdings over the weekend. Who knows what will happen when they wake up on Monday morning? Two things they/we know for sure, though,. 1) Google will pay half a billion at least. 2) ZTE will settle with 200 million at least. We just don't know when.

  • pagesus52 by pagesus52 Aug 4, 2014 7:25 AM Flag

    "The NIH recently gave Geisbert's lab a five-year, $26 million grant to research three of the most promising treatments for Ebola. These include a man-made antibody treatment; a promising Canadian drug from Tekmira Pharmaceuticals shown to protect monkeys from Ebola; and a vaccine that can be used both to prevent infection and also treat it."
    "One of our goals is to start combining these treatments, like we do with AIDS medications," Geisbert said.

  • 1.4 billion... half for pip means 700 million...6 months appeal time discount cuts it to 350 million... 56 mill shares outstanding... worth 5-6 dollars as of now... is it a reasonable expectation coming Monday?

    I think in the next few months a hedge fund will step in to buy both companies at 7 dollars apiece to end this madness. That would be the best outcome for both companies. Hope cool heads will prevail. A big win for pip, for sure.

    shorts will be fried next Monday.

0.1064-0.0016(-1.48%)Aug 21 2:06 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.